
What an mRNA melanoma vaccine may mean for cancer treatment
Episode 1385
A new mRNA vaccine for melanoma is making headlines. Moderna and Merck recently announced results from their clinical trial suggesting that this new vaccine, in combination with the cancer drug Keytruda, reduced recurrence rates in patients. The companies have not yet released full data from the trial. So, how does the vaccine work? And does this mark the beginning of a new era of cancer treatments using mRNA vaccine technology? Ira talks with physician Michael Postow, whose patients were part of the drug trial at Memorial Sloan Kettering Cancer Center. Guest: Dr. Michael...
Publisher
Science Friday
Link
www.wnycstudios.org/podcasts/science-friday
Published
September 3, 2026
Duration
12 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Science Friday and WNYC Studios
Science Friday
@sciencefriday
#mrnamelanomavaccine #cancertreatment
